Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trial.

Moser T, Hitzl W, Lerda-Casaccia T, Unterhofer M, Demjaha R, Martinez-Serrat M, Khalil M, Harrer A, Böhm B, Hofbauer P, Cadamuro J, Huber-Schönauer U, Trinka E, Wipfler P

Open source

DOI
10.1093/brain/awag099
Published
2026 Jul 6
Container
Brain : a journal of neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/brain/awag099,
  title = {Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trial.},
  author = {Moser T and Hitzl W and Lerda-Casaccia T and Unterhofer M and Demjaha R and Martinez-Serrat M and Khalil M and Harrer A and Böhm B and Hofbauer P and Cadamuro J and Huber-Schönauer U and Trinka E and Wipfler P},
  year = {2026},
  journal = {Brain : a journal of neurology},
  doi = {10.1093/brain/awag099},
  url = {https://doi.org/10.1093/brain/awag099}
}

RIS

TY  - JOUR
TI  - Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trial.
AU  - Moser T
AU  - Hitzl W
AU  - Lerda-Casaccia T
AU  - Unterhofer M
AU  - Demjaha R
AU  - Martinez-Serrat M
AU  - Khalil M
AU  - Harrer A
AU  - Böhm B
AU  - Hofbauer P
AU  - Cadamuro J
AU  - Huber-Schönauer U
AU  - Trinka E
AU  - Wipfler P
PY  - 2026
JO  - Brain : a journal of neurology
DO  - 10.1093/brain/awag099
UR  - https://doi.org/10.1093/brain/awag099
ER  - 

APA

T, M., W, H., T, L., M, U., R, D., M, M., M, K., A, H., B, B., P, H., J, C., U, H., E, T., & P, W. (2026). Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trial.. Brain : a journal of neurology. https://doi.org/10.1093/brain/awag099

Source records